HANDOFF
|
|
|
William Beaumont Hospital Sued for Disability Discrimination Against Nurse
|
|
|
The US Equal Employment Opportunity Commission is suing Michigan’s William Beaumont Hospital for failing to accommodate a registered nurse with a disability. She had a medical work restriction but was told she couldn’t work fewer than 32 hours in her then-current position. Rather than transfer the nurse to another position she could perform within her work hours restriction, the hospital made her apply and compete for vacant positions, which the EEOC determined violates the Americans with Disabilities Act.
|
|
|
First Fully AI-Generated Drug Enters Human Trials
|
|
|
We recently wrote about the potential issues with artificial intelligence in healthcare, but here’s a potential benefit: drug production. The first fully AI-generated drug, a treatment for idiopathic pulmonary fibrosis, has entered clinical trials with human patients. The founder of the drug-manufacturing startup Insilico Medicine said it’s the
“first drug with both a novel AI-discovered target and a novel AI-generated design.” The company has two other partially AI-generated drugs in the clinical stage, one for Covid-19 and the other a USP1 inhibitor for treating solid tumors.
|
|
|
WHO: Aspartame Sweetener Is a Possible Carcinogen
|
|
|
The World Health Organization’s cancer research arm, the International Agency for Research on Cancer, is set to label the aspartame artificial sweetener as a possible carcinogen this month. The ruling, however, doesn’t specify how much aspartame someone can safely consume — the Joint WHO and Food and Agriculture Organization’s
Expert Committee on Food Additives will announce a recommendation later this month. The International Sweeteners Association said the WHO’s aspartame review is based on “heavily discredited research” and “may mislead consumers.”
|
|
|
